Obstructive Sleep Apnea and Chronic Opioid Use

被引:0
作者
Christian Guilleminault
Michelle Cao
Herbert J. Yue
Pawan Chawla
机构
[1] Stanford University Sleep Medicine Division,
[2] Stanford Sleep Medicine Clinic,undefined
来源
Lung | 2010年 / 188卷
关键词
Opioids; Positive-pressure therapy; Obstructive sleep apnea; Central sleep apnea; Pain;
D O I
暂无
中图分类号
学科分类号
摘要
The use of opioids has been associated with development of sleep-disordered breathing, including central apneas, nocturnal oxygen desaturations, and abnormal breathing patterns. We describe sleep-disordered breathing and its subsequent treatment in a group of obstructive sleep apneic patients on chronic opioid therapy. Clinical evaluation followed by diagnostic overnight polysomnogram was performed in subjects on chronic opioid therapy who met the study criteria. All subjects had an initial CPAP titration followed by a repeat clinical evaluation. Subjects with an apnea-hypopnea index (AHI) ≥ 5 continued to report symptoms and had follow-up titration with bilevel positive therapy; then bilevel positive-pressure therapy with a back-up rate was then performed. Age-, sex-, and disease-severity-matched obstructive sleep apnea patients served as controls. Forty-four study participants, including a large group of women (50%), and 44 controls were enrolled in the study. Opioid subjects had AHI = 43.86 ± 1.19, with a central apnea index of 0.64 ± 1.36. Two abnormal breathing patterns were seen, including decreased inspiratory effort during an obstructive event and longer than expected pauses in breathing. Despite adequate titration with CPAP and bilevel positive-pressure therapy, nocturnal awakenings and central apnea awakenings persisted (AHI and central apnea indices of 13.81 ± 2.77 and 11.52 ± 2.12, respectively). Treatment with bilevel positive-pressure therapy with a back-up rate controlled the problem. Nonobese OSA patients with opioid intake have obstructive breathing with a different pattern. In this study, bilevel positive-pressure therapy with a back-up rate was the most effective treatment.
引用
收藏
页码:459 / 468
页数:9
相关论文
共 123 条
  • [1] Walker JM(2007)Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing J Clin Sleep Med 3 455-462
  • [2] Farney RJ(2005)Central sleep apnea in stable methadone maintenance treatment patients Chest 128 1348-1356
  • [3] Rhondeau SM(2003)Sleep-disordered breathing associated with long-term opioid therapy Chest 123 632-639
  • [4] Boyle KM(2001)Sleep-disordered breathing in stable methadone program patients: a pilot study Addiction 96 395-403
  • [5] Valentine K(2008)Adaptive servoventilation in patients with sleep disordered breathing associated with chronic opioids medications for nonmalignant pain J Clin Sleep Med 4 311-319
  • [6] Cloward TV(2008)Adaptive support servoventilation: a novel treatment for sleep apnea associated with use of opioids J Clin Sleep Med 4 305-310
  • [7] Shilling KC(1994)The sleep disorders questionnaire I: creation and multivariate structure of SDQ Sleep 17 160-167
  • [8] Wang D(1991)A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale Sleep 14 540-545
  • [9] Teichtahl H(1999)Clinical predictors of obstructive sleep apnea Laryngoscope 109 1901-1907
  • [10] Drummer O(1985)A clinical sign to predict difficult tracheal intubation: a prospective study Can Anesth Soc J 32 429-434